
bt_headshoulder_aapl_returnopt
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -85 Days active 427 …
tickers: TMDX
source: Benzinga
ticker | polarity | why? |
---|---|---|
TMDX | negatively | The ticker TMDX will likely be affected negatively by this lawsuit due to the allegations of securities fraud, which can erode investor confidence and lead to a decrease in stock value. Additionally, the claims of improper business practices and safety issues may result in regulatory scrutiny and potential penalties, further impacting the company’s financial performance and market perception. |
None so far…
NEW YORK, March 4, 2025 — Levi & Korsinsky, LLP has initiated a class-action securities lawsuit against TransMedics Group, Inc. (TMDX). The lawsuit aims to recover losses for TransMedics investors who were allegedly affected by securities fraud between February 28, 2023, and January 10, 2025. The complaint alleges that TransMedics and its executives made false statements and concealed critical information. Specifically, the lawsuit claims that the company used improper practices, including: ● KICKBACKS, fraudulent overbilling, and coercive tactics to generate business and revenue. ● ENSGAGED in unsafe practices and hid safety issues, lacking proper safety oversight. TransMedics faced heightened risks of scrutiny and regulatory issues as a result. Investor Options and Next Steps Investors who suffered losses during the specified period have until April 15, 2025, to request the court to appoint them as the lead plaintiff. Shareholders may be entitled to compensation without incurring any out-of-pocket costs or fees. About Levi & Korsinsky, LLP The team at Levi & Korsinsky has secured hundreds of millions of dollars for shareholders over the past 20 years. They have ranked as one of the top securities litigation firms in the United States.
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -85 Days active 427 …
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -60 Days active 408 …
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. 19 Days active 410 …